Library / regulatory-reference
Thailand: Thai Food and Drug Administration (Thai FDA)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Thai Food and Drug Administration is Thailand's national regulator for medicines, medical devices, food, cosmetics and hazardous substances, operating under the Ministry of Public Health.
Thailand is one of Southeast Asia's larger health-product markets with a strong domestic manufacturing base, and the Thai FDA's registrations and safety communications are followed across the region.
How products enter the market
Medicines require registration before marketing, with classification into categories that determine how they may be sold, from prescription-only through pharmacy-dispensed to household remedies available in general shops, a long-standing feature of the Thai system.
Medical devices moved to a risk-based licensing framework aligned with regional harmonization, and the agency also licenses manufacturing and import establishments and supervises product advertising.
Regional and international role
The Thai FDA is a leading participant in Southeast Asian regulatory harmonization and in regional vaccine and biological-product oversight capacity-building. Thailand's position as a clinical-trials and medical-tourism hub keeps the agency closely engaged with international sponsors.
The agency cooperates with regional neighbors on substandard and falsified product control, a persistent cross-border challenge in the area.
Using this profile
The Thai FDA publishes registers, guidance and announcements in Thai, with some English material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the Thai FDA illustrates the multi-category Southeast Asian regulator, with a distinctive medicines-classification ladder controlling where products may be sold and a regional leadership role in harmonization.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.